Neuland Pharma Research Private Limited - Company Profile

It is a business outsourcing private limited company based in Hyderabad, Telangana, India, established in 2012.

2012 Hyderabad, Telangana, India Amalgamated

Last Updated: July 27, 2025

About Neuland Pharma Research Private Limited

Neuland Pharma Research Private Limited, a amalgamated private limited company, was established on 23 April 2012 in Hyderabad, Telangana, India. Engaging in accounting and financial analysis within the professional, scientific and technical sector, it holds CIN: U73100TG2012PTC080474. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹9.50 Cr and a paid-up capital of ₹5.00 Cr.

Formerly known as Sucheth & Saharsh Pharmaceutical Research Private Limited. Employing 230 professional, Its leadership includes Ramamohan Davuluri Rao (Director), Saharsh Rao Davuluri (Director), Sucheth Rao Davuluri (Director). Past directors included Tirunelveli Padmanabhan Devarajan, Viswanath Venkata Subrahmanya Anjaneya Chibrolu. It holds no open charges and ₹261.90 Cr settled loans. Its latest AGM occurred on 28 December 2017, with the balance sheet filed on 31 March 2017. It is based at Sanali Info Park, 'A' Block, Ground Floor, 8-2-120/113, Road No. 2, Banjara Hills,, Hyderabad, Telangana, 500034.

Company Details

CIN/LLPIN
U73100TG2012PTC080474
Registration Number
080474
Incorporation Date
23 April 2012
Authorized Capital
₹9.50 Cr
Paid-Up Capital
₹5.00 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Amalgamated

Key Metrics

Authorised Capital ₹ 9.50 Cr as on 27-07-2025
Paid Up Capital ₹ 5.00 Cr as on 27-07-2025
Company Age 13 Year, 10 Months
Last Filing with ROC 31 Mar 2017
Satisfied Charges ₹ 261.90 Cr as on 27-07-2025
Revenue Growth **** 23.87% (FY 2017)
Profit Growth **** 169.49% (FY 2017)
Ebitda **** 220.62% (FY 2017)
Net Worth 62.63% (FY 2017)
Total Assets **** 29.45% (FY 2017)

Comprehensive Company Insights

Explore comprehensive insights into Neuland Pharma Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Neuland Pharma Research Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ramamohan Davuluri Rao	Director	23 Apr 2012	Current
Saharsh Rao Davuluri	Director	23 Apr 2012	Current
Sucheth Rao Davuluri	Director	23 Apr 2012	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	22 Jun 2017	Past
Pramod Abcsdd	Alternate Director	22 Jun 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neuland Pharma Research.

Neuland Pharma Research Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 23.87% increase. The company also saw a substantial improvement in profitability, with a 169.49% increase in profit. The company's net worth Soared by an impressive increase of 62.63%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

23.87%

*******

Revenue from Operations

*******

22.70%

*******

Total Assets

*******

29.45%

*******

Profit or Loss

*******

169.49%

*******

Net Worth

*******

62.63%

*******

EBITDA

*******

220.62%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neuland Pharma Research?

In 2017, Neuland Pharma Research had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹2,619,000,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 150.90 Cr
Export-Import Bank Of India : 76.00 Cr
Bank Of India : 20.00 Cr
Sbi Global Factors Limited : 15.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Jun 2014	Bank Of India	₹20.00 Cr	Satisfied
08 Aug 2013	Export-Import Bank Of India	₹10.00 Cr	Satisfied
08 Aug 2013	Export-Import Bank Of India	₹30.00 Cr	Satisfied
08 Aug 2013	Sbi Global Factors Limited	₹15.00 Cr	Satisfied
08 Aug 2013	Export-Import Bank Of India	₹36.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Neuland Pharma Research?

Unlock and access historical data on people associated with Neuland Pharma Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Neuland Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuland Pharma Research's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neuland Pharma Research

Recent Activity within the Organization

Annual General Meeting

The activity Neuland Pharma Research Private Limited last Annual general meeting of members was held on 28 Dec 2017 as per latest MCA records. was completed.
28 Dec 2017
Charges

Progress on A charge registered on 27 Jun 2014 via Charge ID 10507554 with Bank Of India was fully satisfied on 07 Aug 2017. was documented.
07 Aug 2017
Balance Sheet

The activity Neuland Pharma Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad. was completed.
31 Mar 2017
Charges

The activity A charge registered on 08 Aug 2013 via Charge ID 10445664 with Export-Import Bank Of India was fully satisfied on 02 Mar 2017. was completed.
02 Mar 2017
Charges

The activity A charge registered on 08 Aug 2013 via Charge ID 10446304 with Sbi Global Factors Limited was fully satisfied on 27 Oct 2016. was completed.
27 Oct 2016
Charges

Progress on A charge registered on 08 Aug 2013 via Charge ID 10445670 with Export-Import Bank Of India was fully satisfied on 19 Apr 2016. was documented.
19 Apr 2016

Explore recent activity and updates - View Recent Activity